ACR GUIDELINES Bundle (free trial)

ACR Rheumatoid Arthritis RA Guidelines

American College of Rheumatology GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/622897

Contents of this Issue

Navigation

Page 6 of 19

5 DMARD-Naïve Early RA Low Disease Activity Moderate or High Disease Activity Moderate or High Disease Activity a, b Combination Traditional DMARDs a, b or TNF Inhibitor +/- MTX a, b or Non-TNF Biologic +/- MTX a, b Moderate or High Disease Activity See Established RA algorithm Treat to Target c a Also consider using short-term glucocorticoids (defined as <3 months treatment) for RA disease flares. Glucocorticoids should be used at the lowest possible dose and for the shortest possible duration to provide the best benefit-risk ratio for the patient. b Consider adding low-dose glucocorticoids (≤10 mg/day of prednisone or equivalent) in patients with moderate or high RA disease activity when starting DMARDs and in patients with DMARD failure or biologic failure. c Treatment target should ideally be low disease activity or remission. Figure 1. Early Rheumatoid Arthritis DMARD Monotherapy a DMARD Monotherapy a

Articles in this issue

Archives of this issue

view archives of ACR GUIDELINES Bundle (free trial) - ACR Rheumatoid Arthritis RA Guidelines